Myopia glasses may keep working even after kids take them off

NCT ID NCT06884527

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 ยท Last updated Sep 11, 2026

Summary

Researchers are studying whether the benefit of a special spectacle lens for slowing nearsightedness lasts after children stop wearing it. The trial follows 91 children who took part in an earlier three-year study, where some wore the innovative lenses and others wore regular single-vision glasses. For 12 months, all participants switch to single-vision lenses while researchers measure changes in eye focus and eye length. The goal is to see whether myopia progression rebounds or stays slower once the special lenses are removed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an innovative spectacle lens designed to slow myopia progression
What this could lead to
If the lens effect persists after children stop wearing it, eye doctors could recommend a defined course of treatment rather than years of continuous wear.
What could go wrong
This is a small follow-up study of 91 children from one earlier trial. Any rebound in myopia after stopping the lenses may be temporary, and the results may not apply to other children or other lens designs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

91 people

The number who actually took part.

Started

Feb 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 15 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Existing subjects from the NCT05174780 clinical study. * Ability to comply with study procedures. * Informed consent of parent/guardian and assent of subject. Exclusion Criteria: * Current ocular infection, inflammation, or irritation likely to affect vision.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Illinois College of Optometry

    Chicago, Illinois, 60616, United States

  • Kannarr Eye Care

    Pittsburg, Kansas, 66762, United States

  • New England College of Optometry

    Boston, Massachusetts, 02115, United States

  • SUNY College of Optometry

    New York, New York, 10036, United States

  • Sacco Eye Group

    Vestal, New York, 13850, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.